Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

Article type

Case Report


Article page

246-249


Authors Details

Bhagwati Prasad Sharma, Shashikant Sharma*


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 491

PDF Downloaded: 342


Management of Coats’ disease with RazumabTM (World’s first biosimilar ranibizumab) and laser photocoagulation: A case report


Case Report

Author Details : Bhagwati Prasad Sharma, Shashikant Sharma*

Volume : 7, Issue : 1, Year : 2021

Article Page : 246-249

https://doi.org/10.18231/j.ijceo.2021.050



Suggest article by email

Get Permission

Abstract

We report a case of a 19-year-old Indian male with stage 2 Coats’ disease who was managed with monthly intravitreal biosimilar ranibizumab injections (n=3) along with laser photocoagulation in the right eye. Post-treatment, significant reductions were seen in the exudation, angioma-like lesions, central macular thickness and edema in the retina. At the last follow-up at 9 months after intravitreal biosimilar ranibizumab initiation, distant vision improved from best corrected visual acuity (BCVA) of 5/60 at baseline to 6/18, and near vision from ‘not able to read’ to N/12 in the right eye.

Keywords: Biosimilar, Coats’ disease, Laser photocoagulation, Ranibizumab.


How to cite : Sharma B P , Sharma S , Management of Coats’ disease with RazumabTM (World’s first biosimilar ranibizumab) and laser photocoagulation: A case report. Indian J Clin Exp Ophthalmol 2021;7(Special Issue):246-249

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.